Medications for post-traumatic stress disorder
Pro Research Analysisby 
Searched over 200M research papers
First-Line Medications for Post-Traumatic Stress Disorder (PTSD): SSRIs and SNRIs
Selective serotonin reuptake inhibitors (SSRIs) are the most widely recommended and best-studied medications for PTSD. Sertraline and paroxetine are the only drugs officially approved for PTSD treatment in several countries, and they are often used alongside psychotherapy for better results 19. Other SSRIs, such as fluoxetine, have also shown small but statistically significant benefits in reducing PTSD symptoms 2345+2 MORE.
Serotonin-norepinephrine reuptake inhibitors (SNRIs), particularly venlafaxine, have also demonstrated a small positive effect and are considered a potential first-line option 3568.
Efficacy and Limitations of Antidepressant Medications
While SSRIs and SNRIs are effective for some patients, their overall impact is modest, and many individuals do not achieve full remission of symptoms 1234+3 MORE. The effect sizes in clinical trials are generally small, and about half of patients may not experience significant improvement 1234.
Other Pharmacological Options: Antipsychotics and Augmentation Strategies
Atypical antipsychotics, such as quetiapine, risperidone, and olanzapine, have shown some benefit, especially for patients with specific symptoms like hyperarousal or re-experiencing 1356. Quetiapine, in particular, is recommended for patients with these symptoms .
Augmentation strategies, where another medication is added to an antidepressant, have shown small positive effects for prazosin (an alpha-1 adrenergic blocker, often used for nightmares) and risperidone 36.
Off-Label and Emerging Treatments
Other medications, such as antiepileptics, benzodiazepines, and mood stabilizers, are sometimes used off-label, but evidence supporting their effectiveness is limited or lacking 16. Benzodiazepines, despite their use in practice, do not have strong evidence for benefit in PTSD .
Emerging treatments, including drugs targeting new biological pathways and the use of psychedelics in combination with psychotherapy, are under investigation but require more research before they can be recommended 19.
Clinical Considerations and Individualized Treatment
Medication choice should be tailored to the individual, considering the severity of PTSD symptoms, comorbid conditions, and specific symptom clusters . While SSRIs and SNRIs remain the mainstay, antipsychotics and augmentation agents may be considered for patients who do not respond to first-line treatments 356.
Conclusion
SSRIs (sertraline, paroxetine, fluoxetine) and SNRIs (venlafaxine) are the best-supported medications for PTSD, but their benefits are generally modest and many patients do not achieve full remission. Atypical antipsychotics and augmentation strategies offer additional options, especially for treatment-resistant cases or specific symptom profiles. There is a clear need for more effective and better-tolerated medications, and ongoing research is exploring new pharmacological approaches for PTSD 1345+3 MORE.
Sources and full results
Most relevant research papers on this topic